With Fluorescence Or Luminescence Patents (Class 436/172)
-
Patent number: 8263356Abstract: The present invention relates to antibodies, binding portions thereof, or probes that bind specifically to glucosyltransferase enzymes, and uses of these agents for detecting glucosyltransferase enzyme(s) in a sample and for diagnosing predisposition of a human child to early childhood caries. The present invention also relates to a kit for detecting a glucosyltransferase enzyme in an oral sample from an animal.Type: GrantFiled: August 14, 2006Date of Patent: September 11, 2012Assignee: University of RochesterInventors: William H. Bowen, Anne Vacca Smith, Robert Berkowitz
-
Patent number: 8263018Abstract: The present invention relates to devices for detecting the presence or absence of a target molecule or substance, compounds which may be employed in such devices and methods of using such compounds. In some embodiments, the compounds are conjugated polyenes.Type: GrantFiled: April 21, 2006Date of Patent: September 11, 2012Assignee: The Hong Kong University of Science and TechnologyInventors: Ben Zhong Tang, Matthias Haeussler, Yongqiang Dong, Hui Tong
-
Patent number: 8264680Abstract: A biochip reader wherein spectroscopic information of a sample under analysis is arranged in spaces between images of the sample arranged on a biochip. The reader comprises a confocal microscope and the biochip comprises a transparent substrate to allow passage of the excitation light and fluorescent light from the sample with the excitation light being applied from the side opposite that on which the samples are arranged so that noise from dust and the like is avoided by the transmitted light avoiding contact with the dust. Another aspect is an electrophoresis system wherein different coloring material are used for each of a variety of target substances, so that the same lane and area are utilizable to concurrently detect a polychrome fluorescent pattern of the different targets. A confocal scanner or fluorescence imaging system is used with a plurality of filters to detect the multi-colored fluorescences of the target substance.Type: GrantFiled: August 28, 2009Date of Patent: September 11, 2012Assignee: Yokogawa Electric CorporationInventor: Takeo Tanaami
-
Patent number: 8263412Abstract: Engineered fluorescent proteins, nucleic acids encoding them and methods of use.Type: GrantFiled: January 21, 2011Date of Patent: September 11, 2012Assignee: The State of Oregon, Acting by and through the State Board of Higher Education on Behalf of the University of OregonInventors: Rebekka M. Wachter, James S. Remington
-
Patent number: 8263355Abstract: Disclosed is a rapid, non-invasive and highly specific and sensitive diagnostic assay for the identification of individuals with autoimmune chronic urticaria, which makes use of CD203c, and in some embodiments, additional proteins, as a marker for the disease. Test kits for diagnosis of an individual suspected of having autoimmune chronic urticaria are also disclosed. Also disclosed are a method of identifying compounds useful for treating autoimmune chronic urticaria and a method of treating autoimmune chronic urticaria.Type: GrantFiled: June 29, 2010Date of Patent: September 11, 2012Inventors: Ronald Joseph Harbeck, Karen Mary Andrews, Donald MacGlashan, Jr.
-
Publication number: 20120225021Abstract: In the present invention, a method of producing stable bare colloidal gold nanoparticles is disclosed. The nanoparticles can subsequently be subjected to partial or full surface modification. The method comprises preparation of colloidal gold nanoparticles in a liquid by employing a top-down nanofabrication method using bulk gold as a source material. The surface modification of these nanoparticles is carried out by adding one or multiple types of ligands each containing functional groups which exhibit affinity for gold nanoparticle surfaces to produce the conjugates. Because of the high efficiency and excellent stability of the nanoparticles produced by this method, the fabricated gold nanoparticle conjugates can have surface coverage with functional ligands which can be tuned to be any percent value between 0 and 100%.Type: ApplicationFiled: March 2, 2011Publication date: September 6, 2012Inventors: Wei QIAN, Makoto MURAKAMI, Yuki ICHIKAWA, Yong CHE
-
Patent number: 8257925Abstract: A miniaturized assembly is provided whereby a fluid sample can be divided into a plurality of sample portions in retaining wells and the sample fluid can be displaced from open ends of the wells while simultaneously being sealed in the wells. A method of dividing a fluid sample using the assembly is also provided.Type: GrantFiled: May 16, 2011Date of Patent: September 4, 2012Assignees: Applied Biosystems, LLC, The United States of America, as represented Department of Health and Human ServicesInventors: James F. Brown, Jonathan E. Silver
-
Patent number: 8257651Abstract: In one embodiment the present invention provides a blood analyte meter that is user-friendly and easy to use. In accordance with an embodiment of the present invention an analyte measurement device, for use with a test strip for determining the amount of an analyte in a sample, displays a hierarchy of information or options to a user. The hierarchy of information or options may include, among other information or options, subroutines that are performable by the processor of the device, stored data related to past tests performed by the user, and alarm features of the device. A user scrolls through and selects individual options or pieces of information by rotating and translating a rotatable user interface around and along an axis of rotation.Type: GrantFiled: March 16, 2006Date of Patent: September 4, 2012Assignee: AgaMatrix, Inc.Inventors: Joseph Flaherty, Timothy Golnik
-
Patent number: 8257650Abstract: An automated analyzer for analyzing patient samples. The analyzer includes a plurality of cuvettes, which allow the samples to be mixed with various reagents. The analyzer includes one or more detectors, including a detector adapted to detect luminescence of the reaction mixture in the cuvettes. The analyzer allows for various diagnostic assays to be performed on a single system, and provides for high-sensitivity analysis at faster speeds.Type: GrantFiled: January 6, 2010Date of Patent: September 4, 2012Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Allan Tit-Shing Chow, William Jackson Devlin, Sr., Timothy Patrick Evers, David Russell Thompson
-
Patent number: 8257981Abstract: Novel chemical compounds, with application in fluorometric analytical methods, for qualitative and quantitative determination of biomolecules. The aim of the invention is to identify and prove the suitability of such compounds. Said aim is achieved with compounds of formula (1) where R1 is an antenna function, R2 is a chelate forming agent, containing a coordinated lanthanide(III)ion, X is —OH or a group with affinity for the biomolecule, bonded to a carboxylate group of the chelate forming agent by means of an amide bond and Y is —H or a group with affinity for the biomolecule, coupled to the antenna function.Type: GrantFiled: April 30, 2005Date of Patent: September 4, 2012Assignee: Sensient Imaging Technologies GmbHInventors: Jörg Marx, Frank Schumer, Regina Lischewski, Kornelia Zeckert, Hans-Joachim Böhme, Horst Hennig
-
Patent number: 8257982Abstract: A method and a system for jointly determining the content of a first chromophorous and fluorescent compound and a second chromophorous compound in a biological tissue (30). The determination of the content of the chromophorous and fluorescent compound (33) is carried out by optical measurement of the differential absorption of this chromophorous and fluorescent compound (33) and the determination of the content of the second chromophorous compound (34) is carried out by optical measurement of the fluorescence of the chromophorous and fluorescent compound (33). Optical radiations (11-14) are utilized which are suitably chosen in combination with at least one operation of filtering these radiations suited to using single detection (21) and measurement element for the two determinations.Type: GrantFiled: May 7, 2008Date of Patent: September 4, 2012Assignees: FORCE-A, Centre National de la Recherche Scientifique, Universite Paris SudInventors: Zoran Cerovic, Nicolae Moise, Yves Goulas, Jean-Luc Ayral
-
Patent number: 8252607Abstract: The disclosure provides a simple and effective way of synthesizing robust organic-inorganic hybrid gels and ultra-thin films using vaporization of a gel precursor. The gels are synthesized at relatively low temperature allowing the activity of the immobilized species to be maintained. The disclosure provides robust, synthetic, selective, active and/or passive transport systems in the form of functional biologically active species and mechanisms for forming them. These systems allow selective and passive or active transport of ionic, molecular and biological species through the incorporation of functional biological molecules and biomolecular assemblies in a rigid matrix.Type: GrantFiled: June 6, 2008Date of Patent: August 28, 2012Inventors: Gautam Gupta, Gabriel Lopez, Plamen Atanassov
-
Patent number: 8252209Abstract: We have designed a molecular switch based on the photoinduced opening and thermal closing of a [1,3]oxazine ring. A substituted [1,3]oxazine compound described as having a general (i.e., unsubstituted) structure with fused indoline and benzooxazine fragments such that they share a common bond in the [1,3]oxazine compound: (i) the bond connecting positions 1 and 2 of the indoline fragment and (ii) the bond connecting positions 2 and 3 of the benzooxazine fragment. Irradiation by light of suitable wavelength and intensity of this photochromic compound induces cleavage of a [C—O] bond of the [1,3]oxazine ring to form a phenolate chromophore. The photogenerated (e.g., colored) isomer may revert thermally to the starting (e.g., colorless) oxazine. Alternatively, the switch may be between isomers of the compound that absorb at different wavelengths. Reversible coloration of silica or polymeric materials and switching optical signals may involve many cycles of interconversion between different colored states.Type: GrantFiled: August 6, 2010Date of Patent: August 28, 2012Assignee: The University of MiamiInventors: Francisco M. Raymo, Massimiliano Tomasulo
-
Publication number: 20120214194Abstract: The present invention relates to a process for the total synthesis of epicocconone analogs of formula (I): The invention also relates to novel epicocconone analogs.Type: ApplicationFiled: October 25, 2010Publication date: August 23, 2012Applicants: UNIVERSITE DE ROUEN, MACQUARIE UNIVERSITY, INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE ROUEN, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRSInventors: Xavier Franck, Philippe Peixoto, Peter Helmuth Karuso
-
Publication number: 20120214253Abstract: The present invention provides a novel class of macrocyclic compounds as well as complexes formed between a metal (e.g., lanthanide) ion and the compounds of the invention. Preferred complexes exhibit high stability as well as high quantum yields of lanthanide ion luminescence in aqueous media without the need for secondary activating agents. Preferred compounds comprise hydroxypyridinonyl moieties within their macrocyclic structure and are characterized by surprisingly low, non-specific binding to a variety of polypeptides such as antibodies and proteins as well as high kinetic stability.Type: ApplicationFiled: August 24, 2010Publication date: August 23, 2012Applicant: LUMIPHORE, INC.Inventors: Nathaniel G. Butlin, Kenneth N. Raymond, Jide Xu, Anthony D'Aleo
-
Patent number: 8247551Abstract: A fluorophore that forms a complex with Pb ions is disclosed. The fluorophore/lead complex fluoresces with an intensity greater than complexes formed by the fluorophore with other metals. The fluorophore may be used as a sensor/detector for lead ions in various samples. Methods for detecting and calculating the concentration of lead ions in samples are also disclosed.Type: GrantFiled: August 18, 2009Date of Patent: August 21, 2012Assignee: Duquesne University of the Holy SpiritInventors: Partha Basu, Barbara Serli Mitasev, Lauren E. Marbella
-
Patent number: 8246912Abstract: An optical detecting apparatus for a bio-chip, the optical detecting apparatus including: a light source system for illuminating a bio-chip with an excitation light; a fluorescent light detecting system for detecting a fluorescent light emitted by the bio-chip; and a light path altering unit for directing the excitation light emitted by the light source system to a bio-chip and directing the fluorescent light emitted by the bio-chip to the fluorescent light detecting system, wherein a cross-sectional area of the excitation light irradiated by the light source system onto the bio-chip is greater than an area of the bio-chip, and the fluorescent light detecting system detects a fluorescent image of the entire bio-chip with a single illumination of excitation light.Type: GrantFiled: July 31, 2009Date of Patent: August 21, 2012Assignee: Samsung Electronics Co., Ltd.Inventor: Seong-ho Cho
-
Patent number: 8247238Abstract: Provided are methods, devices and systems that utilize free-surface fluidics and SERS for analyte detection with high sensitivity and specificity. The molecules can be airborne agents, including but not limited to explosives, narcotics, hazardous chemicals, or other chemical species. The free-surface fluidic architecture is created using an open microchannel, and exhibits a large surface to volume ratio. The free-surface fluidic interface can filter interferent molecules, while concentrating airborne analyte molecules. The microchannel flow enables controlled aggregation of SERS-active probe particles in the flow, thereby enhancing the detector's sensitivity.Type: GrantFiled: August 25, 2011Date of Patent: August 21, 2012Assignee: The Regents of the University of CaliforniaInventors: Carl D. Meinhart, Brian Piorek, Seung Joon Lee, Martin Moskovits, Sanjoy Banerjee, Juan Santiago
-
Patent number: 8241911Abstract: A calibration card and method of using the card to calibrate an analytical instrument capable of reading a photoluminescent oxygen probe. The card includes at least (a) a first mass of an oxygen sensitive photoluminescent dye retained within a hermetically sealed space so as to isolate the dye from environmental oxygen, and in fluid communication with an activated metal-air battery whereby any oxygen permeating into the hermetically sealed space is quickly consumed by the battery, and (b) a second mass of an oxygen sensitive photoluminescent dye in fluid communication with the environment whereby the second mass of photoluminescent dye is exposed to an environmental concentration of oxygen.Type: GrantFiled: November 19, 2010Date of Patent: August 14, 2012Assignee: Mocon, Inc.Inventors: Timothy A. Ascheman, Daniel W. Mayer, Stephen D. Tuomela
-
Patent number: 8241914Abstract: A method and apparatus for sorting stained particles in a fluid stream, each of the method and apparatus including an epi-illumination optics system with a focusing lens. The optics system being operable to direct a beam of electromagnetic radiation through the focusing lens in a forward direction along a beam axis intersecting particles in the fluid stream at the first location so that the particles pass through the beam, resulting in the fluorescence emissions from the particles being directed along the beam axis in a rearward direction.Type: GrantFiled: May 12, 2011Date of Patent: August 14, 2012Assignee: Inguran LLCInventors: Gary Durack, Jeffrey D. Wallace, Gary P. Vandre, Lon A. Westfall, Jeremy T. Hatcher, Niraj V. Nayak
-
Publication number: 20120202194Abstract: The invention relates to a substance determining apparatus for determining a substance within a fluid. Particles, which have attached the substance, are bound to a binding surface (30). A sensing unit (33) is adapted to generate a sensing signal being indicative of at least one of i) a distance between the particles bound on the binding surface (30) and the binding surface (30) and ii) an in-plane position of the particles bound on the binding surface. A binding discrimination unit (34) is adapted to discriminate between different kinds of binding of the particles bound on the binding surface (30) depending on the generated sensing signal. The binding discrimination unit (34) is preferentially a unit for determining the part of the sensing signal being caused by specifically bound particles and to determine the substance based on this determined part of the sensing signal.Type: ApplicationFiled: September 24, 2010Publication date: August 9, 2012Applicant: KONINKLIJKE PHILIPS ELECTRONICS N.V.Inventors: Toon Hendrik Evers, Johannes Joseph Hubertina Barbara Schleipen, Joannes Baptist Adrianus Dionisius Van Zon, Derk Jan Wilfred Klunder, Josephus Arnoldus Hendricus Maria Kahlman, Ron Martinus Laurentius Van Lieshout, Mikhail Mikhaylovich Ovsyanko, Kim Van Ommering
-
Patent number: 8236555Abstract: The present invention is directed to methods for conducting multiplexed assays. The methods are particularly well suited for measuring a plurality of analytes that may be present in very different abundances. The invention also relates to systems, devices, equipment, kits and reagents for use in such methods.Type: GrantFiled: March 9, 2010Date of Patent: August 7, 2012Assignee: Meso Scale Technologies, LLCInventors: Selen A. Stromgren, Eli N. Glezer
-
Publication number: 20120196375Abstract: The present invention is in the field of household cleaning, for example laundry products and methods. The invention is directed to the use of indicator materials, such as fluorescent indicator materials, for detecting or visualizing organic laundry soils, particularly those that tend to be invisible to the naked eye, such as sebum, perspiration, biological soils, odor-causing soils/stains and tannins. In addition, the present invention is directed to methods of using indicator materials, such as fluorescent indicator materials, to detect such soils on fabrics, and to determine and demonstrate the cleaning efficacy of a laundry product.Type: ApplicationFiled: August 4, 2011Publication date: August 2, 2012Applicant: The Sun Products CorporationInventors: Mark GRANJA, Robert Doris
-
Patent number: 8232112Abstract: Labels and methods of producing labels for use in clinical, analytical and pharmaceutical development assays are provided. Labels may comprise shape-encoded particles which may be coupled to ligands such as DNA, RNA and antibodies, where different shapes are used to identify which ligand(s) are present. Labels may also comprise reflectors, including retroreflectors and retroreflectors susceptible to analyte-dependent assembly for efficient homogeneous assays.Type: GrantFiled: April 28, 2010Date of Patent: July 31, 2012Inventors: Richard C. Willson, Raul Ruchhoedft
-
Patent number: 8232104Abstract: One embodiment of the disclosure relates to a detection system including a chemical taggant and a detector. The chemical taggant may be a chemical not substantially present in an untagged target exhaust plume and able to be disposed in the exhaust system of a target and to enter the exhaust plume of the exhaust system in detectable quantities. The chemical taggant may have one or more distinct energy signatures, such as optical energy signatures, that allow its detection. The detector may be able to detect at least one of these one or more energy signatures of the chemical taggant in the exhaust plume. Another embodiment relates to a method of detecting a target by disposing a chemical taggant in the exhaust system of the target and then detecting the chemical taggant.Type: GrantFiled: May 7, 2009Date of Patent: July 31, 2012Assignee: Raytheon CompanyInventor: Gary A. Frazier
-
Publication number: 20120190125Abstract: This invention includes a compound represented by the following structural formula (I) or an acceptable salt thereof.Type: ApplicationFiled: September 28, 2010Publication date: July 26, 2012Applicant: NATIONAL UNIVERSITY OF SINGAPOREInventors: Bin Liu, Kanyi Pu
-
Patent number: 8227256Abstract: Two-color (two-photon) excitation with two confocal excitation beams is demonstrated with a Raman shifter as excitation light source. Two-color excitation fluorescence is obtained from Coumarin 6H dye sample (peak absorption=394 nm, peak fluorescence=490 nm) that is excited using the first two Stokes outputs (683 nm, 954 nm, two-color excitation=398 nm) of a Raman shifter pumped by a 6.5 nsec pulsed 532 nm-Nd:YAG laser (Repetition rate=10 Hz). The two Stokes pulses overlap for a few nanoseconds and two-color fluorescence is generateven with focusing objectives of low numerical apertures (NA?0.4). We observed the linear dependence of the two-color fluorescence signal with the product of the average intensities of the two Stokes excitation beams. The two-color fluorescence distribution is strongly localized around the common focus of the confocal excitation beams.Type: GrantFiled: September 27, 2002Date of Patent: July 24, 2012Inventors: Caesar A. Saloma, Wilson O. Garcia, Jonathan A. Palero
-
Publication number: 20120183440Abstract: Among donor molecules labeling protein in living cells to be measured, the rate of donor molecules binding to an acceptor molecule and occurring FRET is determined. In a plurality of previous measurement samples having different ratios of first molecule concentration to second molecule concentration, a fluorescence lifetime of the first molecule are calculated and the fluorescence lifetime minimum value of the first molecule is calculated. The samples are irradiated with a laser beam having time-modulated intensity and the fluorescence emitted by the laser-irradiated measurement samples are measured. By using the fluorescent signals thus measured, the fluorescence lifetime of the first molecule is calculated. By using the fluorescence lifetime minimum value of the first molecule and the fluorescence lifetime of the first molecule that is calculated above, the rate of the first molecules occurring FRET in the first molecules in the measurement samples is calculated.Type: ApplicationFiled: September 13, 2010Publication date: July 19, 2012Applicant: MITSUI ENGINEERING & SHIPBUILDING CO.,LTD.Inventors: Shigeyuki Nakada, Hironori Hayashi, Kazuteru Hoshishima
-
Publication number: 20120184456Abstract: The present disclosure relates to methods and systems that may be used for analysis of nutraceutical associated components.Type: ApplicationFiled: January 10, 2012Publication date: July 19, 2012Inventors: Edward K.Y. Jung, Eric C. Leuthardt, Royce A. Levien, Robert W. Lord, Mark A. Malamud, John D. Rinaldo, JR., Lowell L. Wood, JR.
-
Patent number: 8221700Abstract: Systems and methods for improved measurement of absorbance/transmission through fluidic systems are described. Specifically, in one set of embodiments, optical elements are fabricated on one side of a transparent fluidic device opposite a series of fluidic channels. The optical elements may guide incident light passing through the device such that most of the light is dispersed away from specific areas of the device, such as intervening portions between the fluidic channels. By decreasing the amount of light incident upon these intervening portions, the amount of noise in the detection signal can be decreased when using certain optical detection systems. In some embodiments, the optical elements comprise triangular grooves formed on or in a surface of the device. The draft angle of the triangular grooves may be chosen such that incident light normal to the surface of the device is redirected at an angle dependent upon the indices of refraction of the external medium (e.g., air) and the device material.Type: GrantFiled: February 2, 2010Date of Patent: July 17, 2012Assignee: OPKO Diagnostics, LLCInventors: David Steinmiller, Vincent Linder
-
Patent number: 8221648Abstract: The present invention include fluorescent nanocrystals which have high fluorescence intensity, are water soluble, exhibit physical and chemical stability, and whose spectral properties are detectably modified as the size of functional groups bonded to the nanocrystal surface change when contacted with target molecules in a sample. The molecules in the sample add to or reduce the size of functional groups on the fluorescent nanocrystal proportional to the activity and amount of the target molecules. The present invention may be used to detect telomerase in a sample.Type: GrantFiled: September 1, 2009Date of Patent: July 17, 2012Assignee: Life Technologies CorporationInventor: Imad Naasani
-
Publication number: 20120178172Abstract: Polymers and copolymers of polymerizable fluorescent compounds of 7-hydroxycoumarin such as Ethyl-2-methacrylate Umbelliferone-4-acetate are provided. In addition, a sensor comprising this polymer notably for detecting and/or assaying nitrated and organophosphorus compounds, explosives, and toxic compounds is provided.Type: ApplicationFiled: September 24, 2010Publication date: July 12, 2012Applicant: Commissariat a l'energie Atomique et aux energies alternativesInventors: Pierrick Buvat, Lucie Malosse, Alain Siove, Dominique Ades
-
Publication number: 20120178177Abstract: The invention provides novel methods for isolating, characterizing, comparing, and using biological components that are present in the cerebrospinal fluid. Such biological structures, called CS-MPs, can be used for identifying biomarkers that reflect the status (or anticipate the development) of disorders of the Central nervous System (CNS). The novel methods, biological products, and related kits make possible the use of CS-MPs and of their components as biomarkers for the diagnosis, prognosis, or monitoring of CNS disorders. The CS-MPs have a diameter comprised between 100 and 1000 nm and contain phosphatidylserine (PS).Type: ApplicationFiled: August 13, 2010Publication date: July 12, 2012Inventors: Philippe Delerive, Zouher Majd
-
Publication number: 20120178171Abstract: The present invention concerns a method of measuring the concentration of an analyte in an aqueous solution that comprises the steps of: obtaining an aqueous solution containing an analyte, providing a cyanine indicator, placing the aqueous solution in fluid communication with the cyanine indicator, measuring a detectable property change of the cyanine indicator, and comparing the detectable property change of the cyanine indicator with a calibration curve of the detectable property change of samples containing known concentrations of the analyte to determine the concentration of the analyte, wherein the detectable property change is proportional to the concentration of the analyte in said aqueous solution.Type: ApplicationFiled: January 12, 2011Publication date: July 12, 2012Applicant: GENERAL ELECTRIC COMPANYInventors: Bingzhi Chen, Caibin Xiao, Hong Xu, Alan M. Agree, Chunbo Yu
-
Patent number: 8216854Abstract: The present invention is directed to a system, device and method for measuring the concentration of an analyte in a fluid or matrix. A thermodynamically stabilized analyte binding ligand for use in the system, device and method is disclosed. The thermodynamically stabilized analyte binding ligand is resistant to degradation at physiological temperatures and its use within the device provides a minimally invasive sensor for monitoring the concentration of an analyte in a fluid or matrix as are present in the body of an animal.Type: GrantFiled: November 1, 2006Date of Patent: July 10, 2012Assignee: BioTex, Inc.Inventors: Ralph Ballerstadt, Roger McNichols, Ashok Gowda
-
Patent number: 8216856Abstract: The invention relates to a detectable molecule comprising a biospecific binding reactant attached to a luminescent lanthanide chelate comprising a lanthanide ion and a chelating ligand of the formula (I) wherein, R1A R1B are independently of each other selected from the group consisting of hydrogen, methyl, ethyl, —COOH, —COO—, —CH2COOH, —CH2COO—, hydroxyl or OR2; R2 is selected from the group consisting of —CH3, —C(CH3)3, —C(CR4)3, wherein R4 is an alkyl with 1 to 6 carbon atoms, —CH2COOH, —CH2COO?, and appropriate hexose residues; R3 is a linker for coupling to a biospecific binding reactant selected from the group consisting of thiourea (—NH—CS—NH—), aminoacetamide (—NH—CO—CH2—NH—), amide (—NH—CO— and —CO—NH—), aliphatic thioether (—S—), disulfide (—S—S—) and 6-substituted-1,3,5-triazine-2,4-diamine; and the lanthanide ion is selected from the group consisting of europium(III), terbium(III), dysprosium(III) and samarium(III). The invention also relates to corresponding lanthanide chelates.Type: GrantFiled: August 17, 2007Date of Patent: July 10, 2012Assignee: Abacus Diagnostica OyInventors: Harri Takalo, Jouko Kankare, Elina Tienari
-
Patent number: 8216827Abstract: The disclosure relates to a biological analysis device including: means for circulating a fluid to be analyzed, comprising a fluidic chamber, optical detection means based on a semiconductor, including a detection front face, a rear face and pads of electrical contacts located on this rear face.Type: GrantFiled: January 31, 2006Date of Patent: July 10, 2012Assignees: Commissariat a l'Energie Atomique, Biomerieux SAInventors: Patrick Pouteau, Raymond Campagnolo, Frederic Mallard, Frederic Ginot
-
Patent number: 8216788Abstract: The present disclosure relates to methods and compositions for the detection of infectious proteins or prions in samples, including the diagnosis of prion related diseases. One embodiment is an ultrasensitive method for detecting PrP-res (PrPSc) that allows the use of recombinant PrP-sen (rPrP-sen) as a substrate for seeded polymerization. A sample is mixed with purified rPrP-sen to make a reaction mix which is incubated to permit aggregation of the rPrP-sen with the PrP-res that may be present in the sample. Any aggregates are intermittently disaggregated by agitation (for example by sonication) and the reaction allowed to proceed to amplify target substrate. Any rPrP-res(Sc) in the reaction mix is detected to indicate the presence of PrP-res in the original sample. This assay, which is called rPrP-PMCA, is surprisingly much faster than existing PMCA methods, yet it still retains sufficient sensitivity to detect extremely low levels of PrP-res.Type: GrantFiled: July 21, 2008Date of Patent: July 10, 2012Assignee: The United States of America as represented by the Secretary of the Department of Health and Human ServicesInventors: Byron W. Caughey, Ryuichiro Atarashi, Roger A. Moore
-
Patent number: 8218141Abstract: An apparatus and a method for optically analyzing a sample are provided. The apparatus includes a first optical device that transmits a narrow waveband of light and has a first filter and a first monochromator that provide different paths for the narrow waveband of the light. The apparatus may also include a light source that generates the light as broadband excitation light, in which case the first optical device transmits a narrow waveband of the broadband excitation light through the first filter or the first monochromator. Further, the apparatus may include a second optical device that directs the narrow waveband of the broadband excitation light onto the sample and receives emission light from the sample, a third optical device that transmits a narrow waveband of the emission light, and a detector that converts the narrow waveband of the emission light into an electrical signal.Type: GrantFiled: July 19, 2010Date of Patent: July 10, 2012Assignee: BTI Holdings, Inc.Inventors: Oleg Zimenkov, Xavier Amouretti, Robert M. Gifford, Mark R. Kennedy, Michael Kontorovich, Ben Norris, Richard N. Sears, Dan Venditti, Christopher Many
-
Publication number: 20120171776Abstract: The disclosure relates to a method of detecting analytes using non-aromatic dendritic macromolecules. The inherent photoluminescence of dendrimers are utilized to detect analytes which are electron deficient in nature.Type: ApplicationFiled: September 10, 2010Publication date: July 5, 2012Applicant: INDIAN INSTITUTE OF SCIENCEInventors: Narayanaswamy Jayaraman, Govindasamy Jayamurugan, Yamajala Bhaskara Rama Dur Rajesh, Bagul Rahul Suresh, Ajay Kumar Sood
-
Publication number: 20120171703Abstract: The present invention relates to compound of formula I: and their use as chemiluminescent and/or bioluminescent reagents.Type: ApplicationFiled: July 12, 2010Publication date: July 5, 2012Applicant: UNIVERSITÁ DEGLI STUDI DI SIENAInventors: Germano Giuliani, Andrea Cappelli, Maurizio Anzini, Salvatore Vomero
-
Patent number: 8211367Abstract: A method of separating a cell-containing sample into a substantially cell-depleted portion, and a cell-containing portion comprising at least one of a stem cell, a lymphocyte, and a leukocyte comprises a step in which the sample is received in a vessel with at least one flexible wall. In another step, an additive and particles are added to the sample, wherein the additive substantially binds to the at least one of the stem cell, lymphocyte, and leukocyte, and the particles and wherein the particles substantially bind to the at least one of the stem cell, lymphocyte, and leukocyte, and the additive, thereby producing a cell-containing network. In a further step, the network is separated from the substantially cell-depleted portion by applying a magnetic force.Type: GrantFiled: January 18, 2011Date of Patent: July 3, 2012Inventors: James Wyatt, Matthew Scott, Vijay Mahant
-
Patent number: 8211660Abstract: The present invention provides methods and systems for performing in vivo flow cytometry. In one embodiments, selected circulating cells of interest of a subject are labeled with fluorescent probe molecules. The labeled cells are irradiated in-vivo so as to excite the fluorescent probes, and the radiation emitted by the excited probes is detected, preferably confocally. The detected radiation is then analyzed to derive desired information, such as relative cell count, of the cells of interest. In some embodiments, the circulating cells comprise apoptotic cells whose detection can allow, e.g., non-invasive monitoring of the efficacy of a cancer treatment, such as an anti-tumor or an anti-angiogenic therapy.Type: GrantFiled: May 24, 2010Date of Patent: July 3, 2012Assignee: The General Hospital CorporationInventors: Charles P. Lin, Xunbin Wei, Dorothy Sipkins
-
Patent number: 8206987Abstract: A system and method for sorting a mixture of stained particles in a fluid flow path, including stained particles from two distinguishable groups. The system and method can include an electromagnetic radiation source for exciting fluorescence emissions from the stained particles, a photodetector for detecting the fluorescence emissions from the stained particles, a processor for classifying the stained particles; and a photo-damaging laser for damaging selected particles in the flow path.Type: GrantFiled: May 12, 2011Date of Patent: June 26, 2012Assignee: Inguran LLCInventors: Gary Durack, Jeffrey D. Wallace, Gary P. Vandre, Lon A. Westfall, Jeremy T. Hatcher, Niraj V. Nayak
-
Patent number: 8206939Abstract: The present invention provides an approach for the simultaneous determination of the activation states of a plurality of proteins in single cells. This approach permits the rapid detection of heterogeneity in a complex cell population based on activation states, and the identification of cellular subsets that exhibit correlated changes in activation within the cell population. Moreover, this approach allows the correlation of cellular activities or properties. In addition, the use of potentiators of cellular activation allows for characterization of such pathways and cell populations.Type: GrantFiled: May 2, 2011Date of Patent: June 26, 2012Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Omar D. Perez, Garry P. Nolan, Jonathan M. Irish
-
Patent number: 8209128Abstract: This invention provides a new method for rapidly analyzing single bioparticles to assess their material condition and state of health. The method is enabled by use of a resonant cavity apparatus to measure an optical property related to the bioparticle size and refractive index. Measuring the refractive index is useful for determining material properties of the bioparticle. The material properties depend on the biomolecular composition of the bioparticle. The biomolecular composition is, in turn, dependent on the state of health of the bioparticle. Thus, measured optical properties can be used to differentiate normal (healthy) and abnormal (diseased) states of bioparticles derived from cells or tissues. The method is illustrated with data obtained from a resonator with a gain medium. The invention also provides new methods for making multiple measurements in a single device and detecting, analyzing, and manipulating bioparticles that are much smaller than the wavelength of light.Type: GrantFiled: February 20, 2008Date of Patent: June 26, 2012Inventor: Paul L. Gourley
-
Publication number: 20120156797Abstract: In a nanochannel thin film in which oxide layers have surfactant micelles therein, the presence of a target substance in a sample solution is detected with a luminescence intensity of a thin film provided by recognition of the target substance with a luminescent recognition reagent in the nanochannels. Upon focusing on a hydrophobic field provided by the presence of the surfactant in pores of a nanometer size, the novel development of a sensor function is enabled.Type: ApplicationFiled: March 10, 2008Publication date: June 21, 2012Inventors: Tatsuya Uchida, Norio Teramae, Yasuo Suto
-
Publication number: 20120156794Abstract: The invention relates to a method for analysis of fat-soluble components, in particular fat-soluble dyes, from biological materials, in particular foods and feeds, having facilitated extraction of the fat-soluble components from the biological materials with use of suitable dilution solutions and of the extractability using pertinent organic solvents or organic solvent mixtures and also an enrichment and separation method, with subsequent digital evaluation and documentation. It is proposed to treat the biological materials first with a dilution medium which makes the fat-soluble components more readily extractable from the complex biological matrix and subsequently with at least one organic solvent which extracts the components; the substances extracted into the organic supernatant are subsequently chromatographically enriched and separated and then visually assessed and/or measured.Type: ApplicationFiled: May 6, 2011Publication date: June 21, 2012Inventor: Florian SCHWEIGERT
-
Publication number: 20120156793Abstract: The invention provides fluorophores of formulae (I) and (II) and also fluorescent sensor compounds comprising fluorophore moieties based on such fluorophores in combination with a receptor moiety. There is further provided a method of sensing the presence of a target analyte using the fluorescent sensor compound, as well as the use of the fluorescent sensor compounds to sense a target analyte.Type: ApplicationFiled: April 8, 2010Publication date: June 21, 2012Inventor: Timothy Charles Higgs
-
Patent number: 8202734Abstract: A test device and method for determining the presence or absence of an analyte in a fluid sample, the test device including a support bearing a mark thereon, and a matrix defining an axial flow path. In operation, an observation area in the test device becomes transparent, thereby allowing the user to view a mark that is present on a support that is disposed beneath the observation area. Typically, the mark on the underlying support is configured as a minus (?) sign. In the absence of analyte in the sample, the test device presents a negative result as a minus (?) signal. In the presence of analyte in the sample, however, the mark operates in concert with a perpendicular test line on the observation area to present a positive result as a plus (+) signal that is visible to the user.Type: GrantFiled: April 14, 2009Date of Patent: June 19, 2012Assignee: Quidel CorporationInventors: Jeremy Jerome, Mark Daquipa, Bruce Jacono, Hans Boehringer